Dopamine-Related Reduction of Semantic Spreading Activation in Patients With Parkinson’s Disease

Frontiers in Human Neuroscience 16 (2022)
  Copy   BIBTEX

Abstract

Impaired performance in verbal fluency tasks is a frequent observation in Parkinson’s disease. As to the nature of the underlying cognitive deficit, it is commonly attributed to a frontal-type dysexecutive syndrome due to nigrostriatal dopamine depletion. Whereas dopaminergic medication typically improves VF performance in PD, e.g., by ameliorating impaired lexical switching, its effect on semantic network activation is unclear. Data from priming studies suggest that dopamine causes a faster decay of semantic activation spread. The aim of the current study was to examine the impact of dopaminergic medication on the dynamic change of word frequency during VF performance as a measure of semantic spreading activation. To this end, we performed a median split analysis of word frequency during phonemic and semantic VF task performance in a PD group tested while receiving dopaminergic medication as well as after drug withdrawal, and in a sample of age-matched healthy volunteers. Dopaminergic medication in the PD group significantly affected phonemic VF with improved word production as well as increased error-rates. The expected decrease of word frequency during VF task performance was significantly smaller in the PD group ON medication than in healthy volunteers across semantic and phonemic VF. No significant group-difference emerged between controls and the PD group in the OFF condition. The comparison between both treatment conditions within the PD group did not reach statistical significance. The observed pattern of results indicates a faster decay of semantic network activation during lexical access in PD patients on dopaminergic medication. In view of improved word generation, this finding is consistent with a concept of more focused neural activity by an increased signal-to-noise ratio due to dopaminergic neuromodulation. However, the effect of dopaminergic stimulation on VF output suggests a trade-off between these beneficial effects and increased error-rates.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,349

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

The biochemical bases of the placebo effect.Raúl de la Fuente-Fernández & A. Jon Stoessl - 2004 - Science and Engineering Ethics 10 (1):143-150.
Dopamine, Parkinson's disease, and volition.Jon C. Horvitz - 2002 - Behavioral and Brain Sciences 25 (5):586-586.
Reduction in the Biomedical Sciences.Holly Andersen - 2016 - In Miriam Solomon, Jeremy Simon & Harold Kincaid (eds.), Routledge Companion to Philosophy of Medicine. Routledge.

Analytics

Added to PP
2022-04-10

Downloads
10 (#1,160,791)

6 months
7 (#425,192)

Historical graph of downloads
How can I increase my downloads?